2017
DOI: 10.1080/10717544.2016.1236846
|View full text |Cite
|
Sign up to set email alerts
|

Polyphenols delivery by polymeric materials: challenges in cancer treatment

Abstract: Nanotechnology can offer different solutions for enhancing the therapeutic efficiency of polyphenols, a class of natural products widely explored for a potential applicability for the treatment of different diseases including cancer. While possessing interesting anticancer properties, polyphenols suffer from low stability and unfavorable pharmacokinetics, and thus suitable carriers are required when planning a therapeutic protocol. In the present review, an overview of the different strategies based on polymer… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
29
0
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 53 publications
(31 citation statements)
references
References 249 publications
(311 reference statements)
1
29
0
1
Order By: Relevance
“…On the other hand, when the cancer cells were treated with free drugs for 24h, antagonistic effects were observed for all the tested concentrations (CI > 1.2), becoming synergistic only after 48 h incubation with 22 µmol L −1 MTX. This is in accordance with our expectation and with literature data proving the ability of polyphenol conjugates and nanoparticle systems to increase the therapeutic efficiency of conventional anticancer drugs [16,40]. The therapeutic performance of the proposed nanoformulation, which can potentially accumulate in cancer tissues by the enhanced permeability and retention (EPR) effect, will be further investigated in suitable xenograft models, with the aim to evaluate both the pharmacokinetics profiles and the anticancer activity in vivo.…”
Section: Pharmaceuticals 2020 13 X For Peer Review 7 Of 13supporting
confidence: 89%
“…On the other hand, when the cancer cells were treated with free drugs for 24h, antagonistic effects were observed for all the tested concentrations (CI > 1.2), becoming synergistic only after 48 h incubation with 22 µmol L −1 MTX. This is in accordance with our expectation and with literature data proving the ability of polyphenol conjugates and nanoparticle systems to increase the therapeutic efficiency of conventional anticancer drugs [16,40]. The therapeutic performance of the proposed nanoformulation, which can potentially accumulate in cancer tissues by the enhanced permeability and retention (EPR) effect, will be further investigated in suitable xenograft models, with the aim to evaluate both the pharmacokinetics profiles and the anticancer activity in vivo.…”
Section: Pharmaceuticals 2020 13 X For Peer Review 7 Of 13supporting
confidence: 89%
“…Nano-size drug particles can solve the problem and penetrate into solid tumors, due to the same nano-size property 12,13 . Therefore, along with the necessity for effective cancer therapy, high cellular uptake of NPs containing drugs may enhance the internalization of chemicals into cancer cells which leads to the improvement of anticancer efficacy 14 . In the recent years, amphiphilic copolymers with hydrophobic and hydrophilic segments have attracted considerable attention due to their unique phase behavior in the aquatic environment and potential applications for drug delivery systems [15][16][17][18] .…”
mentioning
confidence: 99%
“…Such tunable antioxidant activity is a desirable feature for either biomedical or food applications. The ability to quench free radical species, indeed, can help in preserving the biological environment from oxidative stress, or extending the shelf‐life of foodstuffs …”
Section: Resultsmentioning
confidence: 99%